A Human Serum-Based Enzyme-Free Continuous Glucose Monitoring Technique Using a Needle-Type Bio-Layer Interference Sensor
The incidence of diabetes is continually increasing, and by 2030, it is expected to have increased by 69% and 20% in underdeveloped and developed countries, respectively. Therefore, glucose sensors are likely to remain in high demand in medical device markets. For the current study, we developed a n...
Main Authors: | Dongmin Seo, Sung-Ho Paek, Sangwoo Oh, Sungkyu Seo, Se-Hwan Paek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-09-01
|
Series: | Sensors |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8220/16/10/1581 |
Similar Items
-
Carbon Nanotubes Based Glucose Needle-type Biosensor
by: Hong Li, et al.
Published: (2008-03-01) -
Glucose monitoring technologies - complementary or competitive? Role of continuous glucose monitoring versus flash glucose monitoring versus self-monitoring of blood glucose
by: Jothydev Kesavadev, et al.
Published: (2017-01-01) -
Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients
by: Reha Erkoc, et al.
Published: (2004-01-01) -
Feasibility and acceptability of ambulatory glucose profile in children with Type 1 diabetes mellitus: A pilot study
by: Sushma Rai, et al.
Published: (2016-01-01) -
Determination of Postprandial Glycemic Responses by Continuous Glucose Monitoring in a Real-World Setting
by: Martin Röhling, et al.
Published: (2019-09-01)